CM
IRWD icon

Capula Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Capula Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,925
Closed -$156K – 477
2021
Q3 		$156K Sell
11,925
-9,600
-45% -$124K ﹤0.01% 807
2021
Q2 		$277K Buy
+21,525
New +$246K ﹤0.01% 596

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Capula Management's IRWD Position: Q4 2021 in Review

Capula Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 11,925 shares — an estimated $156K sold.

Capula Management first reported a position in IRWD in Q2 2021 and held it in 2 quarters. The position peaked at $277K in Q2 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Capula Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Capula Management sold 11,925 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $156K.
  • Capula Management first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Capula Management's Ironwood Pharmaceuticals position peaked at $277K in Q2 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Capula Management's 13F filing for Q4 2021, filed 14 Feb 2022.